MYC and neoplasm: The c-Myc oncogene-mediated inhibition of succinate dehydrogenase complex subunit A (SDHA) via acetylation and activation of deacetylase degradation pathways leads to cellular succinate accumulation, further triggering H3K4me3 activation, tumor-specific gene expression, and, thus, tumor progression [170].